Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.26T
Revenue (ttm)	496.48B
Net Income (ttm)	124.14B
Shares Out	n/a
EPS (ttm)	51.13
PE Ratio	18.17
Forward PE	16.15
Dividend	1.28 (2.04%)
Ex-Dividend Date	Aug 26, 2025

Volume	2,505
Average Volume	3,113
Open	63.36
Previous Close	63.36
Day's Range	62.64 - 63.48
52-Week Range	54.62 - 66.01
Beta	0.39
RSI	43.99
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD